Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.
Clinical trial NCT00503971 · TERMINATED
Trial details
- NCT number
- NCT00503971
- Sponsor
- Spanish Lung Cancer Group
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.